{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:51:35Z","timestamp":1785174695317,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA258621"],"award-info":[{"award-number":["R01 CA258621"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA036727"],"award-info":[{"award-number":["P30 CA036727"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bmc.2026.118636","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T15:51:16Z","timestamp":1773589876000},"page":"118636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Incorporation of an alpha-hydroxy substituent modulates activity of triazole bisphosphonate-based geranylgeranyl diphosphate synthase inhibitors"],"prefix":"10.1016","volume":"137","author":[{"given":"Md Ayub","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci L.","family":"Haney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Wiemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Holstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118636_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115493","article-title":"Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton","volume":"139","author":"Rogers","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bmc.2026.118636_bb0010","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/cncr.11128","article-title":"Antitumor effects of bisphosphonates","volume":"97","author":"Green","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.bmc.2026.118636_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of their pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bmc.2026.118636_bb0020","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.1543","article-title":"Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo","volume":"27","author":"Roelofs","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bmc.2026.118636_bb0025","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.bmcl.2012.11.089","article-title":"Triazole-based inhibitors of geranylgeranyltransferase II","volume":"23","author":"Zhou","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118636_bb0030","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.bmc.2014.03.014","article-title":"Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase","volume":"22","author":"Zhou","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118636_bb0035","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/acsmedchemlett.5b00334","article-title":"Potent triazole bisphosphonate inhibitor of geranylgeranyl diphosphate synthase","volume":"6","author":"Wills","year":"2015","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118636_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/mol.116.107326","article-title":"Olefin isomers of a triazole bisphosphonate synergistically inhibit geranylgeranyl diphosphate synthase","volume":"91","author":"Allen","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2026.118636_bb0045","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.bmc.2017.02.066","article-title":"Bishomoisoprenoid triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase","volume":"25","author":"Wills","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118636_bb0050","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bmc.2017.10.023","article-title":"Alpha-methylation enhances the potency of isoprenoid triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors","volume":"26","author":"Matthiesen","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118636_bb0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1124\/jpet.119.258624","article-title":"In vivo evaluation of isoprenoid triazole bisphosphonate inhibitors of geranylgeranyl diphosphate synthase: impact of olefin stereochemistry on toxicity and biodistribution","volume":"371","author":"Haney","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2026.118636_bb0060","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1038\/s41388-019-0794-6","article-title":"Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma","volume":"38","author":"Haney","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2026.118636_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ddr.22012","article-title":"Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma","volume":"84","author":"Haney","year":"2023","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2026.118636_bb0070","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s10637-018-0571-3","article-title":"Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor","volume":"36","author":"Haney","year":"2018","journal-title":"Investig New Drugs"},{"key":"10.1016\/j.bmc.2026.118636_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105528","article-title":"In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway","volume":"167","author":"Haney","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmc.2026.118636_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40164-022-00261-6","article-title":"Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma","volume":"11","author":"Haney","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.bmc.2026.118636_bb0085","article-title":"Geranylgeranyl diphosphate synthase inhibition impairs osteoclast differentiation, morphology, and resorptive activity","volume":"9","author":"Muehlebach","year":"2025","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bmc.2026.118636_bb0090","doi-asserted-by":"crossref","unstructured":"Fairweather AER, Goetz DB, Schroeder CM, et al: Impact of \u03b1-modifications on the activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors. Bioorg Med Chem 2021; 44:116307. Doi: https:\/\/doi.org\/10.1016\/j.bmc.2021.116307.","DOI":"10.1016\/j.bmc.2021.116307"},{"key":"10.1016\/j.bmc.2026.118636_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22060886","article-title":"Recent advances in the development of mammalian geranylgeranyl diphosphate synthase inhibitors","volume":"22","author":"Haney","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118636_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126633","article-title":"Omega-Hydroxy isoprenoid bisphosphonates as linkable GGDPS inhibitors","volume":"29","author":"Bhuiyan","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118636_bb0105","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1021\/ja050622q","article-title":"The allylic azide rearrangement: achieving selectivity","volume":"127","author":"Feldman","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2026.118636_bb0110","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1016\/S0040-4039(01)01844-5","article-title":"A mild and efficient one-pot synthesis of 1-hydroxymethylene-1,1-bisphosphonic acids. Preparation of new tripod ligands","volume":"42","author":"Lecouvey","year":"2001","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmc.2026.118636_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113241","article-title":"Synthesis and preliminary anticancer evaluation of new triazole bisphosphonate-based isoprenoid biosynthesis inhibitors","volume":"214","author":"Legigan","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118636_bb0120","doi-asserted-by":"crossref","first-page":"7148","DOI":"10.1002\/ejoc.201101094","article-title":"A one-pot synthesis of 1-Hydroxy-1,1-bis(phosphonic acid)s starting from the corresponding carboxylic acids","volume":"2011","author":"Egorov","year":"2011","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmc.2026.118636_bb0125","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mrc.1270070907","article-title":"C-13 NMR spectra of monoterpenes","volume":"7","author":"Bohlmann","year":"1975","journal-title":"Organic Magn Resonance"},{"key":"10.1016\/j.bmc.2026.118636_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129659","article-title":"Alpha-amino bisphosphonate triazoles serve as GGDPS inhibitors","volume":"102","author":"Gehrke","year":"2024","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118636_bb0135","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1016\/j.tet.2015.10.024","article-title":"A practical, chemoselective approach to O-methylation of carboxylic acids with dimethyl malonate","volume":"71","author":"Mao","year":"2015","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2026.118636_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118140","article-title":"Impact of fixed phosphorus position on activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors","volume":"122","author":"Ayub Ali","year":"2025","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118636_bb0145","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.leukres.2010.08.008","article-title":"Isoprenoid biosynthetic pathway inhibition disrupts monoclonal protein secretion and induces the unfolded protein response pathway in multiple myeloma cells","volume":"35","author":"Holstein","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.bmc.2026.118636_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/febs.70181","article-title":"A somatic multiple myeloma mutation unravels a mechanism of oligomerization-mediated product inhibition in GGPPS","author":"Yehia","year":"2025","journal-title":"FEBS J"},{"key":"10.1016\/j.bmc.2026.118636_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100038","article-title":"Structure activity relationship of isoprenoid triazole bisphosphonate-based geranylgeranyl diphosphate synthase inhibitors: effects on pharmacokinetics, biodistribution and hepatic transporters","author":"Haney","year":"2025","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bmc.2026.118636_bb0160","first-page":"134","article-title":"Phosphonates as analogs of biological phosphates","author":"Blackburn","year":"1981","journal-title":"Chem Ind"},{"key":"10.1016\/j.bmc.2026.118636_bb0165","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1039\/c39810000930","article-title":"Monofluoro- and difluoro-methylenebisphosphonic acids: isopolar analogues of a pyrophosphoric acid","author":"Blackburn","year":"1981","journal-title":"J Chem Soc Chem Commun"},{"key":"10.1016\/j.bmc.2026.118636_bb0170","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1021\/jm7015792","article-title":"Determination of the microscopic equilibrium dissociation constants for risedronate and its analogues reveals two distinct roles for the nitrogen atom in nitrogen-containing bisphosphonate drugs","volume":"51","author":"Hounslow","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118636_bb0175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.leukres.2009.06.035","article-title":"Differential activities of thalidomide and isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells","volume":"34","author":"Holstein","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.bmc.2026.118636_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ultsonch.2010.04.006","article-title":"Swift and efficient sono-hydrolysis of nitriles to carboxylic acids under basic condition: role of the oxide anion radical in the hydrolysis mechanism","volume":"18","author":"Lignier","year":"2011","journal-title":"Ultrason Sonochem"},{"key":"10.1016\/j.bmc.2026.118636_bb0185","series-title":"Synthesis of N-Heterocycle Based Phosphonates as Inhibitors of Protein Prenylation","author":"Bhuiyan","year":"2019"},{"key":"10.1016\/j.bmc.2026.118636_bb0190","doi-asserted-by":"crossref","first-page":"9438","DOI":"10.1021\/acs.joc.6b01693","article-title":"Stereoselective synthesis of homoneryl and homogeranyl triazole bisphosphonates","volume":"81","author":"Matthiesen","year":"2016","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.bmc.2026.118636_bb0195","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0145-2126(00)00162-4","article-title":"Interaction of cytosine arabinoside and lovastatin in human leukemia cells","volume":"25","author":"Holstein","year":"2001","journal-title":"Leuk Res"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:58:49Z","timestamp":1779425929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626000921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"alternative-id":["S0968089626000921"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118636","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporation of an alpha-hydroxy substituent modulates activity of triazole bisphosphonate-based geranylgeranyl diphosphate synthase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118636"}}